Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maintenance intravenous iron in hemodialysis patients to minimize erythropoietin doses
TCTR20190707001Phase 3Completed
- Sponsor
- The Kidney Foundation of Thailand
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Iron in end-stage kidney disease (ESKD), anaemia, sponsored by The Kidney Foundation of Thailand. Started Jul 2019; status: completed.
02
Drugs
Iron
03
Conditions
end-stage kidney disease (ESKD)anaemia
Beyond the preview
Go deeper on TCTR20190707001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190707001.